More precisely defined dose distributions are unlikely to affect cancer mortality

Medical Physics

Volumn 30, Issue 2, 2003, Pages 276-

  Schulz, R J ^a   Kagan, A Robert ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; DOSE DISTRIBUTIONS;

ANTINEOPLASTIC AGENT;

BEAM THERAPY; CANCER; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; COST BENEFIT ANALYSIS; HEALTH CARE COST; HUMAN; LETTER; MAGNETIC FIELD; MEDICARE; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; REIMBURSEMENT; UNITED STATES;

EID: 0037320280     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.1532590     Document Type: Letter

References (5)

1. F. D. Becchetti, J. M. Sisterson, and W. R. Hendee, "High energy electron beams shaped with applied magnetic fields could provide a competitive and cost-effective alternative to proton and heavy-ion radiotherapy," Med. Phys. 29, 2435-2437 (2002).
2. M. Goitein, A. J. Lomax, and E. S. Pedroni, "Treating cancer with protons," Phys. Today 55, 45-50 (2002).
3. R. Nath and R. J. Schulz, "Modification of electron beam dose distributions by transverse magnetic fields," Med. Phys. 5, 226-230 (1978).
4. R. Nath, R. J. Schulz, and P. Bongiomi, "Response of mammalian cells irradiated with 30 MV x rays in the presence of a uniform 20-kilogauss magnetic field," Int. J. Radiat. Biol. 38, 285-292 (1980).
5. M. Weinhous, R. Nath, and R. J. Schulz, "Enhancement of electron beam dose distributions by longitudinal magnetic fields: Monte Carlo simulations and magnet systems optimization," Med. Phys. 12, 598-603 (1985).